Complete Filing Data
Accustem Sciences Inc. reported Stockholders Equity of -$139.6 thousand for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Accustem Sciences Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Research And Development Expense | $138.3K | $139.7K | $266.9K | $73.3K |
| Operating Income Loss | -$1.5M | -$2.1M | -$3.7M | -$670.6K |
| Operating Expenses | $1.5M | $2.1M | $3.7M | $670.6K |
| Net Income Loss | -$1.5M | -$2.1M | -$3.7M | -$670.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.5M | -$2.1M | -$3.7M | -$670.6K |
| General And Administrative Expense | $1.4M | $1.9M | $3.5M | $597.3K |
| Comprehensive Income Net Of Tax | -$3.7M | -$682.2K | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$67.0K | -$9.8K | ||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $11.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $72.7K | $60.2K | $28.3K | $31.4K | $41.7K | $23.2K | $20.0K | $14.6K | $15.6K | $58.3K | $54.4K | $21.1K | $14.1K | $30.2K | $2.7K |
| Operating Income Loss | -$399.9K | -$401.4K | -$440.4K | -$328.2K | -$278.2K | -$526.6K | -$598.5K | -$372.8K | -$833.3K | -$899.1K | -$1.1M | -$790.5K | -$62.7K | -$50.5K | -$13.9K |
| Operating Expenses | $399.9K | $401.4K | $440.4K | $328.2K | $278.2K | $526.6K | $598.5K | $372.8K | $833.3K | $899.1K | $1.1M | $790.5K | $62.7K | $50.5K | $13.9K |
| Net Income Loss | -$399.9K | -$401.4K | -$440.4K | -$328.2K | -$278.2K | -$526.6K | -$598.5K | -$372.8K | -$833.3K | -$899.1K | -$1.1M | -$790.5K | -$62.7K | -$50.5K | -$13.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$399.9K | -$401.4K | -$440.4K | -$328.2K | -$278.2K | -$526.6K | -$598.5K | -$372.8K | -$833.3K | -$899.1K | -$1.1M | -$790.5K | -$62.7K | -$50.5K | -$13.9K |
| General And Administrative Expense | $327.2K | $341.2K | $412.1K | $296.8K | $236.5K | $503.4K | $578.6K | $358.2K | $817.7K | $840.9K | $1.0M | $769.4K | $48.6K | $20.3K | $11.2K |
| Comprehensive Income Net Of Tax | -$833.3K | -$899.1K | -$1.1M | -$790.5K | -$96.2K | -$50.1K | $2.8K | ||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$67.0K | -$29.4K | $406.00 | $14.4K | |||||||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $33.4K | -$399.00 | -$16.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity | -$139.6K | $650.7K | $1.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $734.0K | ||||
| Retained Earnings Accumulated Deficit | -$6.5M | -$4.5M | -$724.9K | ||
| Liabilities Current | $2.2M | $1.1M | $702.7K | ||
| Liabilities And Stockholders Equity | $133.9K | $939.7K | $1.4M | ||
| Liabilities | $2.2M | $1.1M | $702.7K | ||
| Common Stock Value | $11.3K | $11.3K | $10.0K | ||
| Assets Current | $129.8K | $932.0K | $1.4M | ||
| Assets | $133.9K | $939.7K | $1.4M | ||
| Accrued Liabilities Current | $156.4K | $518.6K | $123.2K | ||
| Accounts Payable Current | $578.4K | $311.8K | $388.7K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$16.4K | -$712.5K | $734.0K | ||
| Repayments Of Notes Payable | $133.4K | $343.6K | $338.3K | ||
| Property Plant And Equipment Net | $4.0K | $7.7K | |||
| Notes Payable Current | $55.7K | $106.6K | |||
| Other Liabilities Current | $1.5M | $142.2K | |||
| Subscription Receivable Related Party | -$204.9K | ||||
| Other Assets Current | $29.6K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $67.0K | ||||
| Amendment Of Issuance Of Note Payable For Payment Of Prepaid Expense | -$89.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$2.9M | -$2.5M | -$2.2M | -$3.3M | -$3.2M | -$2.9M | -$2.6M | -$2.1M | -$1.9M | -$1.3M | -$946.7K | $797.7K | $1.7M | $2.7M | $1.2M | $1.3M | $1.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $14.4K | $31.3K | $36.4K | $5.0K | $37.1K | $46.1K | $9.4K | $21.5K | $71.0K | $120.7K | $180.6K | $1.3M | $2.0M | $3.2M | |||
| Retained Earnings Accumulated Deficit | -$9.3M | -$8.9M | -$8.5M | -$8.0M | -$7.7M | -$7.3M | -$7.0M | -$6.3M | -$5.7M | -$5.3M | -$3.5M | -$2.6M | -$1.5M | ||||
| Liabilities Current | $4.5M | $4.1M | $3.7M | $3.4M | $3.3M | $3.0M | $2.7M | $2.1M | $1.8M | $1.2M | $824.9K | $731.4K | $561.1K | ||||
| Liabilities And Stockholders Equity | $1.6M | $1.6M | $1.6M | $50.9K | $103.8K | $139.7K | $50.9K | $257.6K | $458.5K | $247.6K | $1.6M | $2.4M | $3.3M | ||||
| Liabilities | $4.5M | $4.1M | $3.7M | $3.4M | $3.3M | $3.0M | $2.7M | $2.1M | $1.8M | $1.2M | $824.9K | $731.4K | $561.1K | ||||
| Common Stock Value | $16.1K | $16.1K | $16.1K | $12.1K | $11.3K | $11.3K | $11.3K | $11.3K | $11.3K | $11.3K | $11.3K | $11.3K | $11.3K | ||||
| Assets Current | $1.6M | $1.6M | $1.6M | $50.4K | $102.5K | $137.4K | $47.8K | $252.6K | $452.7K | $240.8K | $1.6M | $2.4M | $3.2M | ||||
| Assets | $1.6M | $1.6M | $1.6M | $50.9K | $103.8K | $139.7K | $50.9K | $257.6K | $458.5K | $247.6K | $1.6M | $2.4M | $3.3M | ||||
| Accrued Liabilities Current | $149.8K | $153.8K | $147.9K | $164.1K | $164.1K | $154.9K | $219.6K | $465.5K | $371.5K | $723.9K | $349.2K | $218.3K | $108.4K | ||||
| Accounts Payable Current | $923.2K | $859.9K | $849.1K | $804.6K | $790.2K | $744.7K | $649.5K | $432.4K | $382.8K | $307.1K | $154.9K | $109.0K | $379.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $31.3K | -$12.1K | -$553.3K | $3.2M | |||||||||||||
| Repayments Of Notes Payable | $25.5K | $55.7K | $107.3K | ||||||||||||||
| Property Plant And Equipment Net | $105.00 | $418.00 | $1.3K | $2.2K | $3.1K | $5.0K | $5.9K | $6.8K | $8.6K | $9.5K | $7.5K | ||||||
| Notes Payable Current | $44.7K | $66.4K | $25.1K | $57.6K | $81.2K | $112.8K | $297.9K | $212.1K | $316.5K | ||||||||
| Other Liabilities Current | $3.4M | $3.1M | $2.7M | $2.4M | $2.3M | $2.0M | $1.8M | $1.1M | |||||||||
| Subscription Receivable Related Party | |||||||||||||||||
| Other Assets Current | $1.5M | $1.5M | $1.5M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | |||||||||||||||||
| Amendment Of Issuance Of Note Payable For Payment Of Prepaid Expense |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $7.6K | -$352.5K | $401.1K | $81.7K |
| Share Based Compensation | $69.7K | $78.6K | $133.9K | $21.3K |
| Increase Decrease In Accounts Payable | $226.2K | $266.5K | -$76.8K | $394.7K |
| Increase Decrease In Due To Related Parties | $134.2K | $66.0K | -$48.6K | |
| Net Cash Provided By Used In Operating Activities | -$664.1K | -$1.6M | -$1.8M | |
| Net Cash Provided By Used In Financing Activities | $647.6K | $903.1K | $2.6M | |
| Increase Decrease In Prepaid Expense | -$165.9K | -$343.1K | -$270.7K | |
| Proceeds From Related Party Debt | $781.1K | $1.2M | ||
| Proceeds From Receipt Of Subscription Receivable | $204.9K | |||
| Proceeds From Issuance Of Common Stock | $2.7M | |||
| Payments To Acquire Property Plant And Equipment | $11.0K | |||
| Net Cash Provided By Used In Investing Activities | -$11.0K | |||
| Increase Decrease In Other Current Assets | -$29.6K | $29.6K | ||
| Increase Decrease In Due From Related Parties Current | $48.6K | -$173.0K | ||
| Increase Decrease In Due From Related Parties | -$1.4M | |||
| Proceeds From Stock Options Exercised | $8.5K | |||
| Increase Decrease In Related Party Receivable | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | -$16.2K | $63.1K | $206.0K | -$14.7K | |||
| Share Based Compensation | $18.1K | $18.2K | $19.9K | $26.2K | $38.0K | $17.0K | |
| Increase Decrease In Accounts Payable | $44.5K | $71.1K | -$4.8K | -$9.7K | $7.0K | ||
| Increase Decrease In Due To Related Parties | -$7.1K | $66.0K | $21.0K | -$117.1K | |||
| Net Cash Provided By Used In Operating Activities | -$290.2K | -$237.4K | -$446.1K | $372.0K | |||
| Net Cash Provided By Used In Financing Activities | $321.5K | $225.2K | -$107.3K | $2.9M | |||
| Increase Decrease In Prepaid Expense | -$31.6K | -$69.9K | -$108.3K | ||||
| Proceeds From Related Party Debt | $347.0K | $280.9K | |||||
| Proceeds From Receipt Of Subscription Receivable | $204.9K | ||||||
| Proceeds From Issuance Of Common Stock | $2.7M | ||||||
| Payments To Acquire Property Plant And Equipment | $8.2K | ||||||
| Net Cash Provided By Used In Investing Activities | -$8.2K | ||||||
| Increase Decrease In Other Current Assets | -$29.6K | ||||||
| Increase Decrease In Due From Related Parties Current | $117.1K | -$6.9K | |||||
| Increase Decrease In Due From Related Parties | $1.4M | ||||||
| Proceeds From Stock Options Exercised | |||||||
| Increase Decrease In Related Party Receivable | $1.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 11.4M | 11.3M | 11.0M | 10.0M |
| Earnings Per Share Basic | $-0.13 | $-0.18 | $-0.34 | $-0.07 |
| Common Stock Shares Outstanding | 11.3M | 11.3M | 10.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 11.3M | 11.3M | 10.0M | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 11.4M | 11.3M | 11.0M | |
| Earnings Per Share Diluted | $-0.13 | $-0.18 | $-0.34 | |
| Shares Issued Pending Noncash Transaction |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 16.1M | 16.1M | 12.7M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Earnings Per Share Basic | $-0.02 | $-0.02 | $-0.03 | $-0.03 | $-0.02 | $-0.05 | $-0.05 | $-0.03 | $-0.07 | $-0.08 | $-0.10 | $-0.08 | $-0.01 | $-0.01 | $0.00 | |
| Common Stock Shares Outstanding | 16.1M | 16.1M | 16.1M | 12.1M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Issued | 16.1M | 16.1M | 16.1M | 12.1M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | |||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 16.1M | 16.1M | 12.7M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | 11.3M | |||||
| Earnings Per Share Diluted | $-0.02 | $-0.02 | $-0.03 | $-0.03 | $-0.02 | $-0.05 | $-0.05 | $-0.03 | $-0.07 | $-0.08 | $-0.10 | |||||
| Shares Issued Pending Noncash Transaction | 1.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $69.7K | $78.6K | $133.9K | $21.3K |
| Depreciation | $3.6K | $3.6K | $3.3K | |
| Additional Paid In Capital | $4.4M | $4.3M | $1.5M | |
| Prepaid Expense Current | $108.4K | $168.4K | ||
| Interest Paid Net | $3.4K | $7.2K | $7.5K | |
| Notes Issued1 | $102.9K | $372.9K | $439.1K | |
| Stock Issued During Period Value Stock Options Exercised | $8.5K | |||
| Stock Issued During Period Value New Issues | $233.7K | $2.7M | ||
| Foreign Currency Transaction Gain Loss Before Tax | $67.0K | |||
| Due To Related Parties Current | $142.2K | $190.8K | ||
| Stock Issued During Period Value Other | $204.9K | |||
| Due From Related Parties Current | $1.4M | |||
| Expenses Settled In Stock | $233.7K | |||
| Stock Issued During Period Shares New Issues | ||||
| Due From Related Parties |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $23.7K | $23.2K | $18.1K | $18.8K | $13.9K | $18.2K | $19.9K | $12.6K | $26.2K | $38.0K | $37.6K | $17.0K | $21.3K | ||||
| Depreciation | $0.00 | $105.00 | $313.00 | $907.00 | $907.00 | $908.00 | $907.00 | $907.00 | $908.00 | $907.00 | $830.00 | $677.00 | $0.00 | $0.00 | |||
| Additional Paid In Capital | $6.3M | $6.3M | $6.3M | $4.7M | $4.4M | $4.4M | $4.4M | $4.4M | $4.4M | $4.3M | $4.3M | $4.2M | $4.2M | ||||
| Prepaid Expense Current | $58.9K | $82.2K | $14.1K | $45.4K | $65.4K | $91.4K | $38.4K | $181.6K | $332.0K | $60.2K | $282.1K | $391.0K | |||||
| Interest Paid Net | $336.00 | $697.00 | $702.00 | ||||||||||||||
| Notes Issued1 | |||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $8.3K | $187.00 | |||||||||||||||
| Stock Issued During Period Value New Issues | $1.6M | $2.7M | |||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $67.0K | ||||||||||||||||
| Due To Related Parties Current | $108.8K | $87.6K | $73.7K | ||||||||||||||
| Stock Issued During Period Value Other | $204.9K | ||||||||||||||||
| Due From Related Parties Current | |||||||||||||||||
| Expenses Settled In Stock | $79.0K | ||||||||||||||||
| Stock Issued During Period Shares New Issues | 10.0M | ||||||||||||||||
| Due From Related Parties | $1.4M |
Most recent annual filing with the SEC: April 3, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.